10Jan2022
Rafael Torres Appointed Managing Director at Altaris
New York, NY—Altaris Capital Partners, LLC (collectively with its affiliates, “Altaris”) is pleased to announce the appointment of Rafael Torres as a Managing Director to lead the firm’s coverage of the life sciences & diagnostics sectors, effective January 1, 2022. Mr….
04Jan2022
Altaris Acquires Meridian Medical Technologies from Pfizer
New York, NY—Altaris Capital Partners, LLC (collectively with its affiliates, “Altaris”) announced today that it completed the acquisition of Meridian Medical Technologies (“Meridian”), a global leader in emergency response and health security solutions with a focus on complex drug-device combination…
21Dec2021
Altaris Closes Sale of BK Medical
New York, NY—Altaris Capital Partners, LLC (collectively with its affiliates, “Altaris”) announced today that it has completed the sale of BK Medical to General Electric Company (NYSE: GE) for a cash purchase price of $1.45 billion. Headquartered in Boston and…
17Dec2021
Altaris to Acquire Johnson Matthey’s Health Business
New York, NY—Altaris Capital Partners, LLC (collectively with its affiliates, “Altaris”) announced today that it has entered into an agreement to acquire Johnson Matthey Health (“JM Health”) from Johnson Matthey PLC (LSE: JMAT) for total consideration of £325 million. The…
11Nov2021
Kindeva Commits to Sustainable Inhaler Production with New Manufacturing Investment
Loughborough, UK, and Saint Paul, MN, US—Kindeva Drug Delivery L.P. (Kindeva) has announced a long-term commitment to manufacture the next generation of pressurized metered-dose inhaler (pMDI) products using lower Global Warming Potential (GWP) propellants.
02Nov2021
Altaris Announces Acquisition of Meridian Medical Technologies from Pfizer
New York, NY—Altaris Capital Partners, LLC (collectively with its affiliates, “Altaris”) announced today that it has entered into an agreement to acquire Meridian Medical Technologies (“Meridian”), a global leader in emergency response and health security solutions with a focus on…
23Sep2021
Altaris Announces Sale of BK Medical
New York, NY—Altaris Capital Partners, LLC (collectively with its affiliates, “Altaris”) announced today that it has entered into an agreement to sell BK Medical to General Electric (“GE”) (NYSE:GE) for a cash purchase price of $1.45 billion. The transaction is expected…
02Aug2021
Altaris Closes Sale of Paramit
New York, NY—Altaris Capital Partners, LLC (collectively with its affiliates, “Altaris”) announced today that it has completed the sale of Paramit to the Tecan Group (SIX Swiss Exchange: TECN) for total upfront consideration of $1.0 billion. Headquartered in Morgan Hill, CA,…
06Jul2021
Altaris Acquires Padagis from Perrigo
New York, NY—Altaris Capital Partners, LLC (collectively with its affiliates, “Altaris”) announced today that it has completed the acquisition of Padagis LLC (“Padagis”), formerly the generic prescription pharmaceuticals business of Perrigo Company plc (NYSE; TASE: PRGO), for total consideration equal…
30Jun2021
Altaris Appoints Tim Callahan, Shawn Cavanagh and Rafael Torres as Operating Partners
New York, NY–Altaris Capital Partners, LLC (collectively with its affiliates, “Altaris”) is pleased to announce the appointment of Tim Callahan, Shawn Cavanagh and Rafael Torres as Operating Partners. Messrs. Callahan, Cavanagh and Torres bring a broad range of experience across…
24Jun2021
Tivity Health Prices New Senior Secured Credit Facilities in Significantly Oversubscribed Transaction, Increasing Financial Flexibility
Nashville, TN/PRNewswire—Tivity Health, Inc. (Nasdaq: TVTY) (the “Company”), a leading provider of healthy life-changing solutions, including SilverSneakers®, today announced the pricing of a $400 million senior secured term loan B facility (the “term facility”) and a $100 million senior secured…
23Jun2021
Altaris Announces Sale of Paramit
New York, NY—Altaris Capital Partners, LLC (collectively with its affiliates, “Altaris”) announced today that it has entered into an agreement to sell Paramit Corporation (“Paramit”) to The Tecan Group (SIX Swiss Exchange: TECN) for a total consideration of $1.0 billion….